Northern Trust Corp Cuts Holdings in Proto Labs, Inc. $PRLB

Northern Trust Corp decreased its position in shares of Proto Labs, Inc. (NYSE:PRLB) by 3.5% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 271,790 shares of the industrial products company’s stock after selling 9,849 shares during the period. Northern Trust Corp’s holdings in Proto Labs were worth $9,524,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. GAMMA Investing LLC boosted its position in shares of Proto Labs by 249.4% during the first quarter. GAMMA Investing LLC now owns 926 shares of the industrial products company’s stock valued at $32,000 after buying an additional 661 shares during the period. Victory Capital Management Inc. bought a new stake in shares of Proto Labs during the first quarter valued at approximately $584,000. CWM LLC raised its stake in shares of Proto Labs by 50.4% during the first quarter. CWM LLC now owns 1,840 shares of the industrial products company’s stock valued at $64,000 after acquiring an additional 617 shares in the last quarter. Bank of America Corp DE raised its stake in shares of Proto Labs by 109.1% during the fourth quarter. Bank of America Corp DE now owns 54,447 shares of the industrial products company’s stock valued at $2,128,000 after acquiring an additional 28,407 shares in the last quarter. Finally, Principal Financial Group Inc. raised its stake in shares of Proto Labs by 2.7% during the first quarter. Principal Financial Group Inc. now owns 122,057 shares of the industrial products company’s stock valued at $4,277,000 after acquiring an additional 3,168 shares in the last quarter. Hedge funds and other institutional investors own 84.54% of the company’s stock.

Insider Buying and Selling at Proto Labs

In other news, CEO Suresh Krishna acquired 1,725 shares of the firm’s stock in a transaction on Monday, August 4th. The stock was acquired at an average price of $43.51 per share, for a total transaction of $75,054.75. Following the completion of the transaction, the chief executive officer owned 18,021 shares in the company, valued at approximately $784,093.71. The trade was a 10.59% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 1.70% of the company’s stock.

Proto Labs Price Performance

NYSE PRLB opened at $49.97 on Friday. The company has a market capitalization of $1.19 billion, a PE ratio of 83.28 and a beta of 1.27. The company has a fifty day moving average of $44.29 and a 200 day moving average of $39.72. Proto Labs, Inc. has a 1 year low of $26.34 and a 1 year high of $51.09.

Proto Labs (NYSE:PRLB) last posted its earnings results on Thursday, July 31st. The industrial products company reported $0.41 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.33 by $0.08. The company had revenue of $135.06 million during the quarter, compared to the consensus estimate of $128.05 million. Proto Labs had a net margin of 2.91% and a return on equity of 2.22%. The firm’s quarterly revenue was up 7.6% on a year-over-year basis. During the same period in the previous year, the firm posted $0.38 earnings per share. Proto Labs has set its Q3 2025 guidance at 0.350-0.430 EPS. Research analysts expect that Proto Labs, Inc. will post 0.81 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of equities analysts recently commented on the stock. Craig Hallum raised shares of Proto Labs from a “hold” rating to a “buy” rating and set a $54.00 price objective for the company in a research note on Friday, August 1st. Cantor Fitzgerald lifted their price target on shares of Proto Labs from $50.00 to $51.00 and gave the stock an “overweight” rating in a report on Friday, August 1st. Finally, Wall Street Zen raised shares of Proto Labs from a “buy” rating to a “strong-buy” rating in a report on Saturday, August 2nd. Two research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $52.50.

Proto Labs Company Profile

Proto Labs, Inc, together with its subsidiaries, operates as a digital manufacturer of custom parts in the United States and Europe. The company offers injection molding; computer numerical control machining; three-dimensional printing; and sheet metal fabrication products. It serves developers and engineers, who use 3D computer-aided design software to design products across a range of end-markets.